Microfluidic radiolabeling of biomolecules with PET radiometals.

PubWeight™: 0.96‹?› | Rank: Top 15%

🔗 View Article (PMC 3514628)

Published in Nucl Med Biol on October 15, 2012

Authors

Dexing Zeng1, Amit V Desai, David Ranganathan, Tobias D Wheeler, Paul J A Kenis, David E Reichert

Author Affiliations

1: Radiological Sciences Division, Mallinckrodt Institute of Radiology, Washington University School of Medicine, 510 South Kingshighway Blvd., St. Louis, MO 63110, USA.

Articles cited by this

Chaotic mixer for microchannels. Science (2002) 8.22

Efficient production of high specific activity 64Cu using a biomedical cyclotron. Nucl Med Biol (1997) 3.25

Control and detection of chemical reactions in microfluidic systems. Nature (2006) 3.09

Multistep synthesis of a radiolabeled imaging probe using integrated microfluidics. Science (2005) 2.83

Coordinating radiometals of copper, gallium, indium, yttrium, and zirconium for PET and SPECT imaging of disease. Chem Rev (2010) 2.70

An assessment of the effects of shell cross-linked nanoparticle size, core composition, and surface PEGylation on in vivo biodistribution. Biomacromolecules (2005) 1.70

Microreactors for radiopharmaceutical synthesis. Lab Chip (2009) 1.69

Chemistry in microstructured reactors. Angew Chem Int Ed Engl (2004) 1.68

(68)Ga-labeled peptides in tumor imaging. J Nucl Med (2005) 1.45

Syntheses of 11C- and 18F-labeled carboxylic esters within a hydrodynamically-driven micro-reactor. Lab Chip (2004) 1.44

Radiolabeling of TETA- and CB-TE2A-conjugated peptides with copper-64. Nat Protoc (2006) 1.42

Alphavbeta3-integrin imaging: a new approach to characterise angiogenesis? Eur J Nucl Med Mol Imaging (2006) 1.39

Positron emission tomography (PET) and microfluidic devices: a breakthrough on the microscale? Angew Chem Int Ed Engl (2007) 1.22

Multimodality tumor imaging targeting integrin alphavbeta3. Biotechniques (2005) 1.17

The application of micro reactors for organic synthesis. Chem Soc Rev (2005) 1.16

High purity production and potential applications of copper-60 and copper-61. Nucl Med Biol (1999) 1.15

Convenient preparation of 68Ga-based PET-radiopharmaceuticals at room temperature. Bioconjug Chem (2008) 1.12

Application of RGD-containing peptides as imaging probes for alphavbeta3 expression. Front Biosci (Landmark Ed) (2009) 1.11

DOTA-D-Tyr(1)-octreotate: a somatostatin analogue for labeling with metal and halogen radionuclides for cancer imaging and therapy. Bioconjug Chem (2002) 1.07

Noninvasive imaging of alphaVbeta3 function as a predictor of the antimigratory and antiproliferative effects of dasatinib. Cancer Res (2009) 1.05

Design and optimization of coin-shaped microreactor chips for PET radiopharmaceutical synthesis. J Nucl Med (2010) 1.05

Targeting alphavbeta3 integrin: design and applications of mono- and multifunctional RGD-based peptides and semipeptides. Curr Med Chem (2010) 1.04

PET (positron emission tomography) imaging of biomolecules using metal-DOTA complexes: a new collaborative challenge by chemists, biologists, and physicians for future diagnostics and exploration of in vivo dynamics. Org Biomol Chem (2008) 1.01

Copper-62-labeled pyruvaldehyde bis(N4-methylthiosemicarbazonato)copper(II): synthesis and evaluation as a positron emission tomography tracer for cerebral and myocardial perfusion. J Nucl Med (1990) 0.99

External imaging of CCND1, MYC, and KRAS oncogene mRNAs with tumor-targeted radionuclide-PNA-peptide chimeras. Ann N Y Acad Sci (2005) 0.99

Novel chelating agents for potential clinical applications of copper. Nucl Med Biol (2002) 0.99

Microfluidic technology for PET radiochemistry. Appl Radiat Isot (2005) 0.92

Microfluidic-based 18F-labeling of biomolecules for immuno-positron emission tomography. Mol Imaging (2011) 0.92

Molecular Mechanics Investigation of Gadolinium(III) Complexes. Inorg Chem (1996) 0.91

Evaluation of bifunctional chelates for the development of gallium-based radiopharmaceuticals. Bioconjug Chem (2010) 0.91

Maximum tolerated dose and large tumor radioimmunotherapy studies of 64Cu-labeled monoclonal antibody 1A3 in a colon cancer model. Clin Cancer Res (1999) 0.91

Microfluidic labeling of biomolecules with radiometals for use in nuclear medicine. Lab Chip (2010) 0.90

Rapid formation of amides via carbonylative coupling reactions using a microfluidic device. Chem Commun (Camb) (2005) 0.90

Microfluidic preparation of [18F]FE@SUPPY and [18F]FE@SUPPY:2--comparison with conventional radiosyntheses. Nucl Med Biol (2010) 0.87

Isomerism of [64Cu-NOTA-Bn]-labeled radiotracers: separation of two complex isomers and determination of their interconversion energy barrier using ion pair chromatography. Inorg Chem (2011) 0.85

A new germanium-63/gallium-68 generator. J Nucl Med (1978) 0.83

Articles by these authors

Frontiers, opportunities, and challenges in biochemical and chemical catalysis of CO2 fixation. Chem Rev (2013) 1.86

Staging the initiation of autoantibody-induced arthritis: a critical role for immune complexes. J Immunol (2004) 1.48

Mutations of the GABA-A receptor alpha1 subunit M1 domain reveal unexpected complexity for modulation by neuroactive steroids. Mol Pharmacol (2008) 1.46

Development of a high-dynamic range, GFP-based FRET probe sensitive to oxidative microenvironments. Exp Biol Med (Maywood) (2011) 1.42

Ionic liquid-mediated selective conversion of CO₂ to CO at low overpotentials. Science (2011) 1.32

Microtopographically patterned surfaces promote the alignment of tenocytes and extracellular collagen. Acta Biomater (2010) 1.09

A multiplexed microfluidic platform for rapid antibiotic susceptibility testing. Biosens Bioelectron (2013) 1.08

Neurosteroid analog photolabeling of a site in the third transmembrane domain of the β3 subunit of the GABA(A) receptor. Mol Pharmacol (2012) 1.05

Cell migration and polarity on microfabricated gradients of extracellular matrix proteins. Langmuir (2006) 1.05

Fabricating complex three-dimensional nanostructures with high-resolution conformable phase masks. Proc Natl Acad Sci U S A (2004) 1.04

Engineering redox-sensitive linkers for genetically encoded FRET-based biosensors. Exp Biol Med (Maywood) (2008) 1.04

Preparation of 66Ga- and 68Ga-labeled Ga(III)-deferoxamine-folate as potential folate-receptor-targeted PET radiopharmaceuticals. Nucl Med Biol (2003) 1.03

Microfluidic Generation of Lipidic Mesophases for Membrane Protein Crystallization. Cryst Growth Des (2009) 1.02

DNA-mediated control of metal nanoparticle shape: one-pot synthesis and cellular uptake of highly stable and functional gold nanoflowers. Nano Lett (2010) 1.01

Microfluidic chip for combinatorial mixing and screening of assays. Lab Chip (2009) 0.97

Fabrication of X-ray compatible microfluidic platforms for protein crystallization. Sens Actuators B Chem (2012) 0.96

Mammalian target of rapamycin and Rictor control neutrophil chemotaxis by regulating Rac/Cdc42 activity and the actin cytoskeleton. Mol Biol Cell (2013) 0.96

N-benzylisatin sulfonamide analogues as potent caspase-3 inhibitors: synthesis, in vitro activity, and molecular modeling studies. J Med Chem (2005) 0.96

[18F]- and [11C]-labeled N-benzyl-isatin sulfonamide analogues as PET tracers for apoptosis: synthesis, radiolabeling mechanism, and in vivo imaging study of apoptosis in Fas-treated mice using [11C]WC-98. Org Biomol Chem (2009) 0.96

Regiospecific control of protein expression in cells cultured on two-component counter gradients of extracellular matrix proteins. Langmuir (2005) 0.95

Subtype selectivity of dopamine receptor ligands: insights from structure and ligand-based methods. J Chem Inf Model (2010) 0.95

Nitrogen-based catalysts for the electrochemical reduction of CO2 to CO. J Am Chem Soc (2012) 0.95

The non-receptor tyrosine kinase Lyn controls neutrophil adhesion by recruiting the CrkL-C3G complex and activating Rap1 at the leading edge. J Cell Sci (2011) 0.92

Twists and turns in the development and maintenance of the mammalian small intestine epithelium. Birth Defects Res C Embryo Today (2005) 0.92

A microfluidic platform for pharmaceutical salt screening. Lab Chip (2011) 0.90

Microfluidic labeling of biomolecules with radiometals for use in nuclear medicine. Lab Chip (2010) 0.90

A carbon-supported copper complex of 3,5-diamino-1,2,4-triazole as a cathode catalyst for alkaline fuel cell applications. J Am Chem Soc (2010) 0.89

Production and purification of gallium-66 for preparation of tumor-targeting radiopharmaceuticals. Nucl Med Biol (2002) 0.89

A microfluidic approach for protein structure determination at room temperature via on-chip anomalous diffraction. Lab Chip (2013) 0.89

A kinetic model to simulate protein crystal growth in an evaporation-based crystallization platform. Langmuir (2007) 0.88

Microfluidic generation of gradient hydrogels to modulate hematopoietic stem cell culture environment. Adv Healthc Mater (2013) 0.87

Ceramic microreactors for on-site hydrogen production from high temperature steam reforming of propane. Lab Chip (2006) 0.87

Quantitation and visualization of tumor-specific T cells in the secondary lymphoid organs during and after tumor elimination by PET. Nucl Med Biol (2004) 0.87

Air-breathing laminar flow-based microfluidic fuel cell. J Am Chem Soc (2005) 0.87

Imaging in real-time with FRET the redox response of tumorigenic cells to glutathione perturbations in a microscale flow. Integr Biol (Camb) (2010) 0.87

Determination of the phase diagram for soluble and membrane proteins. J Phys Chem B (2010) 0.86

Multiplexed detection of nucleic acids in a combinatorial screening chip. Lab Chip (2011) 0.86

Cross metathesis on olefin-terminated monolayers on Si(111) using the Grubbs' catalyst. Langmuir (2006) 0.86

Microfluidic flow-flash: method for investigating protein dynamics. Anal Chem (2007) 0.85

Multilevel microfluidics via single-exposure photolithography. J Am Chem Soc (2005) 0.85

A neurosteroid analogue photolabeling reagent labels the colchicine-binding site on tubulin: a mass spectrometric analysis. Electrophoresis (2012) 0.85

CoMFA and docking study of novel estrogen receptor subtype selective ligands. J Comput Aided Mol Des (2003) 0.84

Chemical Analysis of Drug Biocrystals: A Role for Counterion Transport Pathways in Intracellular Drug Disposition. Mol Pharm (2015) 0.84

Long-term evaluation of TiO2-based 68Ge/68Ga generators and optimized automation of [68Ga]DOTATOC radiosynthesis. Appl Radiat Isot (2012) 0.83

Neurosteroid analogues. 17. Inverted binding orientations of androsterone enantiomers at the steroid potentiation site on γ-aminobutyric acid type A receptors. J Med Chem (2012) 0.83

Microfluidic platform for the study of intercellular communication via soluble factor-cell and cell-cell paracrine signaling. Biomicrofluidics (2014) 0.82

Comparative in vivo behavior studies of cyclen-based copper-64 complexes: regioselective synthesis, X-ray structure, radiochemistry, log P, and biodistribution. J Med Chem (2004) 0.82

Triazine-based tool box for developing peptidic PET imaging probes: syntheses, microfluidic radiolabeling, and structure-activity evaluation. Bioconjug Chem (2014) 0.82

A Stochastic Model for Nucleation Kinetics Determination in Droplet-Based Microfluidic Systems. Cryst Growth Des (2010) 0.81

Simple methods for the direct assembly, functionalization, and patterning of acid-terminated monolayers on Si111. Langmuir (2005) 0.81

Cadherin and integrin regulation of epithelial cell migration. Langmuir (2009) 0.81

Förster resonance energy transfer-based sensor targeting endoplasmic reticulum reveals highly oxidative environment. Exp Biol Med (Maywood) (2012) 0.80

Active control of the depletion boundary layers in microfluidic electrochemical reactors. Lab Chip (2006) 0.80

Docking and 3D-QSAR studies on isatin sulfonamide analogues as caspase-3 inhibitors. J Chem Inf Model (2009) 0.80

A potential Dubin-Johnson syndrome imaging agent: synthesis, biodistribution, and microPET imaging. Mol Imaging (2005) 0.80

In situ deposition and patterning of single-walled carbon nanotubes by laminar flow and controlled flocculation in microfluidic channels. Angew Chem Int Ed Engl (2006) 0.79

Comparison of the binding and functional properties of two structurally different D2 dopamine receptor subtype selective compounds. ACS Chem Neurosci (2012) 0.79

An X-ray transparent microfluidic platform for screening of the phase behavior of lipidic mesophases. Analyst (2013) 0.79

Inhibition of glutathione synthesis distinctly alters mitochondrial and cytosolic redox poise. Exp Biol Med (Maywood) (2014) 0.79

Synthesis and characterization of the copper(II) complexes of new N2S2-donor macrocyclic ligands: synthesis and in vivo evaluation of the (64)Cu complexes. Dalton Trans (2008) 0.79

Use of binding energy in comparative molecular field analysis of isoform selective estrogen receptor ligands. J Mol Graph Model (2004) 0.78

QSAR studies of copper azamacrocycles and thiosemicarbazones: MM3 parameter development and prediction of biological properties. J Med Chem (2005) 0.78

Thiol-based antioxidants elicit mitochondrial oxidation via respiratory complex III. Am J Physiol Cell Physiol (2015) 0.78

Methanol dehydrogenation and oxidation on Pt(111) in alkaline solutions. Langmuir (2006) 0.78

Molecular modeling of hexakis(areneisonitrile)technetium(I), tricarbonyl eta5 cyclopentadienyl technetium and technetium(V)-oxo complexes: MM3 parameter development and prediction of biological properties. J Mol Graph Model (2007) 0.77

Bitropic D3 Dopamine Receptor Selective Compounds s Potential Antipsychotics. Curr Pharm Des (2015) 0.77

Gravity-induced reorientation of the interface between two liquids of different densities flowing laminarly through a microchannel. Lab Chip (2005) 0.77

Transient light-induced intracellular oxidation revealed by redox biosensor. Biochem Biophys Res Commun (2013) 0.77

Mild methods to assemble and pattern organic monolayers on hydrogen-terminated Si(111). Chem Commun (Camb) (2005) 0.77

Laminar flow-based electrochemical microreactor for efficient regeneration of nicotinamide cofactors for biocatalysis. J Am Chem Soc (2005) 0.76

Development of a microfluidic "click chip" incorporating an immobilized Cu(I) catalyst. RSC Adv (2015) 0.76

Cell-laden hydrogels in integrated microfluidic devices for long-term cell culture and tubulogenesis assays. Small (2013) 0.76

Design rules for pumping and metering of highly viscous fluids in microfluidics. Lab Chip (2010) 0.75

Evaluation of N-phenyl homopiperazine analogs as potential dopamine D3 receptor selective ligands. Bioorg Med Chem (2013) 0.75

Effects of detergent β-octylglucoside and phosphate salt solutions on phase behavior of monoolein mesophases. Biophys J (2013) 0.75

CoMSIA and docking study of rhenium based estrogen receptor ligand analogs. Steroids (2007) 0.75

Region specific enhancement of quantum dot emission using interleaved two-dimensional photonic crystals. Appl Opt (2015) 0.75

Double transfer printing of small volumes of liquids. Langmuir (2007) 0.75

Chemical and mechanical modulation of polymeric micelle assembly. Nanoscale (2017) 0.75

A microfluidic platform for evaporation-based salt screening of pharmaceutical parent compounds. Lab Chip (2013) 0.75

High temperature continuous flow synthesis of CdSe/CdS/ZnS, CdS/ZnS, and CdSeS/ZnS nanocrystals. Nanoscale (2015) 0.75

Metastable States of small-molecule solutions. J Phys Chem B (2007) 0.75

Peptide Receptor Radionuclide Therapy With 177Lu-Octreotate in Patients With Somatostatin Receptor Expressing Neuroendocrine Tumors: Six Years' Assessment. Clin Nucl Med (2017) 0.75

Design considerations for electrostatic microvalves with applications in poly(dimethylsiloxane)-based microfluidics. Lab Chip (2012) 0.75

Silver supported on titania as an active catalyst for electrochemical carbon dioxide reduction. ChemSusChem (2014) 0.75

Microfluidic relief for transport limitations. Biotechniques (2005) 0.75

Generalized phase behavior of small molecules and nanoparticles. J Phys Chem B (2007) 0.75

Microfluidic hydrogen fuel cell with a liquid electrolyte. Langmuir (2007) 0.75

Regioselective N-substitution of cyclen with two different alkyl groups: synthesis of all possible isomers. Chem Commun (Camb) (2003) 0.75